Navigation Links
GoInformatics and TeselaGen to Partner on Scientific Data Management Solution
Date:11/15/2013

SOUTH BEND, Ind., and SAN FRANCISCO, Nov. 15, 2013 /PRNewswire-iReach/ -- GoInformatics (http://www.golims.com) and TeselaGen (http://www.teselagen.com) have announced a strategic partnership to offer a state-of-the-art Biological Design Automation and Scientific Data Management platform. With a secure repository to collect, organize, and store research information, the integrated cloud-based platform will enable scientists advance their research at a much faster pace. The cutting-edge biodesign automation tools will provide biologists the ability to engineer cells to more efficiently carry out desirable operations, such as producing medications and vaccines, better seeds and feed options, and converting plant material into high value chemicals and fuels.

Both TeselaGen and GoInformatics employ similar technology architectures that made the partnership a natural extension of each platform. GoInformatics will offer their GoLIMS platform as the infrastructure for research data collection and organization, intellectual property protection, and regulatory reporting. TeselaGen will offer its computer aided design and manufacturing platform for rapid prototyping biomolecules. The integration of GoInformatics LIMS with TeselaGen's bioCAD/CAM platform will offer clients a comprehensive set of design, manufacturing and information management tools. Ultimately, the partnership provides researchers a cost-effective, premium cloud solution for R&D informatics.

"GoInformatics' extensive experience in LIMS and ELN software solutions is a great pairing with our design automation solution," said Michael Fero, CEO, TeselaGen. "Working with our customers in medical and industrial biotechnology, TeselaGen is building the IT backbone for the emerging field of synthetic biology. Through our close collaboration with industry we have built a very economical R&D infrastructure that adds a great deal of real-world value. We think the time is ripe for all of biotech to take advantage of advanced cloud-based tools for their high-value R&D and research CRO management activities. Byte for Byte we generate some of the most valuable data in the world, encoding the next blockbuster drug or high value chemical. Having a LIMS partner like GoInformatics with a nearly identical technology stack will make integration and security provisioning a much easier proposition."

"TeselaGen's experience and capabilities in automated biomolecule design are of enormous value to our clients and prospects", said Chad Gregory, CEO, GoInformatics. "We work closely with biotech companies in RNAi therapeutics, crop science, and animal health and nutrition space where TeselaGen's bioCAD/CAM rapid prototyping tools can be of tremendous value. One of our key initiatives for this year was to find a strategic partner to compliment our product and services and bring meaningful analytical biotechnology tools to our solution set. In TeselaGen we found the ideal partner as both companies are very passionate about helping R&D organizations get more out of their spending and resources by implementing better scientific and technology infrastructures."

About GoInformatics
GoInformatics is a privately held company based in South Bend, IN. The company provides Scientific Data Management tools and services for research and development groups. GoInformatics software solutions were built from the ground up as an exclusively cloud-based technology for research collaboration and organization, intellectual property protection, and regulatory compliance. Since its official launch, GoInformatics' GoLIMS platform has been licensed and adopted by academic institutions and biotech companies around the world. The company's tools have been implemented in Agrotech, Medical Devices, and Pharmaceutical institutions in the areas of discovery, development, and investigative research.  www.golims.com

About TeselaGen
TeselaGen is a synthetic biology platform, enabling the development of viral constructs, biologic medicines, and sustainably sourced chemicals. TeselaGen is privately held and is based in San Francisco, CA. Recently founded by three former Stanford fellows and housed at the QB3 incubator at UCSF, the company has received early recognition in the form of two US National Science Foundation grants, a US Department of Energy grant and a Bio-IT World Best Practices Award. TeselaGen uses its proprietary Synthetic Evolution® technology for efficient rapid prototyping of recombinant molecules. The company's customers that are helping validate its approach include: Amgen (USA), Genomatica (USA), and Redbiotec (Switzerland). www.teselagen.com

Media Contact: Lianne Mink, GoInformatics Inc., 5743873577, press@golims.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE GoInformatics Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. WuXi PharmaTech to Partner with Pharmacyclics
2. Cell Therapeutics to Host Conference Call Today, Friday, November 15, 2013, at 8:30 a.m. Eastern Time, to Discuss Pacritinib Partnership
3. Argos Therapeutics to Present at the Elsevier Therapeutic Area Partnerships Meeting
4. Unique Partnership Lights Up a Parkinsons Disease Research Tool
5. Edith Sanford Breast Cancer Foundation Named Official Charity Partner of Womens Running Series
6. Ventana to partner with Incyte on the development of Companion Diagnostic tests
7. Liaison Healthcare and PointClickCare Partner for Lab Connectivity & Interoperability
8. G1 Therapeutics to Present at Southeast BIO Investor & Partnering Forum
9. SONIFI Healthcare And Insignia Health Partnering To Enhance Patient Engagement
10. HighPoint Solutions and InnoPeritus Partner to Provide Unprecedented Consultative Services in the European Life Sciences Market
11. ECRI Institute PSO and ISMP Partner on PSO Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/13/2017)... ROCKVILLE, Md. , July 13, 2017  New York ... watchers of pharmaceutical markets should be aware of.  From new ... These trends are detailed in a recently completed study, ... following: 1.  Age-Driven ... years, we have been aware of the impact the growing ...
(Date:7/11/2017)... , July 11, 2017  The global market ... revenues of approximately $394.1 million in 2016.  Although in ... of solid growth, in particular as a result of ... practice, and the recent introduction of a significant number ... for less-invasive testing of tumor biomarkers to guide treatment ...
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
Breaking Medicine Technology:
(Date:7/26/2017)... CA 92660 (PRWEB) , ... July 26, ... ... Loss Prevention for on-premises, off and in the cloud ; today announced the ... and scientific algorithms within a simple to use control console for Data Discovery, ...
(Date:7/26/2017)... ... 26, 2017 , ... “We are thrilled to be partnering with Six Month ... an appointment online in real time,” said Keith English, LocalMed CEO. “Allowing patients the ... bring more Six Month Smiles patients to their providers.” , Each month, over 25,000 ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... IDC-Eating ... Medical Director for the treatment program located in Royal Oak, Michigan. IDC, ... investors who are focused on providing the highest standards in the field of eating ...
(Date:7/26/2017)... Monroe, LA (PRWEB) , ... July 26, 2017 , ... ... - 2:00 p.m. at Charles Johnson Park at 3313 Bernstein Park Drive in Monroe ... Amnesty Rally is to help reduce gun violence throughout Monroe. Citizens can ...
(Date:7/26/2017)... Springs, FL (PRWEB) , ... July 26, 2017 ... ... the nation’s leading innovative specialty pharmacies, has released an updated version of the ... the latest guidelines for treating chronic hepatitis C virus (HCV) infection. All of ...
Breaking Medicine News(10 mins):